Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|March 31, 2015
Infratentorial ependymomas--a study of the centre in KatowiceMarek Mandera, Joanna Makarska, Grażyna Sobol, et al.
Journal of Pediatric Hematology/Oncology|January 20, 2012
Rhabdomyolysis: rare complications with a difficult prognosis in the course of anticancer treatmentGrażyna Sobol, Katarzyna Musioł, Agnieszka Mizia-Malarz, et al.
Medycyna Wieku Rozwojowego|May 25, 2006
[Orbital pseudotumour imitating a proliferative process]Grazyna Sobol, Agnieszka Mizia, Katarzyna Musioł, et al.
Pediatric Hematology and Oncology|July 10, 2010
Proangiogenic cytokines vascular-endothelial growth factor and basic fibroblst growth factor in childhood lymphadenopathyAgnieszka Mizia-Malarz, Grazyna Sobol, Katarzyna Musioł, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|January 12, 2023
Cognitive performance of medulloblastoma tumour survivors related to the area of cerebellum damageNatalia Maja Józefacka, Magdalena Dagmara Machnikowska-Sokołowska, Mateusz Franciszek Kołek, et al.
Pediatric Endocrinology, Diabetes, and Metabolism|December 19, 2017
[Difficulties of the therapy in a boy with coexisting type 1 diabetes mellitus and idiopathic thrombocytopenic purpura]Joanna Zarębska, Katarzyna Musioł, Paulina Brożek, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|December 4, 2017
PRES in the course of hemato-oncological treatment in childrenKatarzyna Musioł, Sylwia Waz, Michał Boroń, et al.
Medycyna Wieku Rozwojowego|May 25, 2006
[Mediastinal involvement in the course of proliferative diseases in children in the materials of one institution]Grazyna Sobol, Agnieszka Mizia, Katarzyna Musioł, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|March 10, 2018
Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and LymphomasMałgorzata Janeczko-Czarnecka, Maryna Krawczuk-Rybak, Irena Karpińska-Derda, et al.
Pageof 1